{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:08:43Z","timestamp":1790248123197,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T00:00:00Z","timestamp":1327449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/npp.2011.317","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T01:41:18Z","timestamp":1327542078000},"page":"1323-1337","source":"Crossref","is-referenced-by-count":74,"title":["Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons"],"prefix":"10.1038","volume":"37","author":[{"given":"Irina A","family":"Ionescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik R","family":"Buell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Holsboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,25]]},"reference":[{"key":"BFnpp2011317_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pbb.2006.11.024","volume":"86","author":"KR Bailey","year":"2007","unstructured":"Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN (2007). Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav 86: 8\u201320.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2011317_CR2","unstructured":"Blanco E, Bilbao A, Luque-Rojas MJ, Palomino A, Berm\u00fadez-Silva FJ, Su\u00e1rez J et al (2011). Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors. Psychopharmacology; e-pub ahead of print 2 September 2011."},{"key":"BFnpp2011317_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514\u2013516.","journal-title":"Nat Neurosci"},{"key":"BFnpp2011317_CR4","doi-asserted-by":"publisher","first-page":"e5129","DOI":"10.1371\/journal.pone.0005129","volume":"4","author":"M Bunck","year":"2009","unstructured":"Bunck M, Czibere L, Horvath C, Graf C, Frank E, Kessler MS et al (2009). A hypomorphic vasopressin allele prevents anxiety-related behavior. PLoS ONE 4: e5129.","journal-title":"PLoS ONE"},{"key":"BFnpp2011317_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0196-9781(95)00042-I","volume":"16","author":"NW Bunnett","year":"1995","unstructured":"Bunnett NW, Dazin PF, Payan DG, Grady EF (1995). Characterization of receptors using cyanine 3-labeled neuropeptides. Peptides 16: 733\u2013740.","journal-title":"Peptides"},{"key":"BFnpp2011317_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/jpet.108.143867","volume":"328","author":"V Camarda","year":"2009","unstructured":"Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, Marzola E et al (2009). In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther 328: 549\u2013555.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011317_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2011.02.009","volume":"658","author":"J Cao","year":"2011","unstructured":"Cao J, de Lecea L, Ikemoto S (2011). Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol 658: 16\u201321.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2011317_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.pneurobio.2010.04.006","volume":"91","author":"F Cesca","year":"2010","unstructured":"Cesca F, Baldelli P, Valtorta F, Benfenati F (2010). The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91: 313\u2013348.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2011317_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/YCO.0b013e32831a473d","volume":"22","author":"J-M Cloos","year":"2009","unstructured":"Cloos J-M, Ferreira V (2009). Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 22: 90\u201395.","journal-title":"Curr Opin Psychiatry"},{"key":"BFnpp2011317_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"ER de Kloet","year":"2005","unstructured":"de Kloet ER, Jo\u00ebls M, Holsboer F (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463\u2013475.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2011317_CR11","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/jps.21604","volume":"98","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH (2009a). Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J Pharm Sci 98: 2501\u20132515.","journal-title":"J Pharm Sci"},{"key":"BFnpp2011317_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/jpet.108.145565","volume":"328","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH (2009b). Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J Pharmacol Exp Ther 328: 312\u2013320.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011317_CR13","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99: 1654\u20131673.","journal-title":"J Pharm Sci"},{"key":"BFnpp2011317_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/mp.2010.81","volume":"16","author":"K Domschke","year":"2010","unstructured":"Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P et al (2010). Neuropeptide S receptor gene\u2014converging evidence for a role in panic disorder. Mol Psychiatry 16: 938\u2013948.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2011317_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","volume":"255","author":"C Dufes","year":"2003","unstructured":"Dufes C, Olivier J-C, Gaillard F, Gaillard A, Couet W, Muller J-M (2003). Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Int J Pharm 255: 87\u201397.","journal-title":"Int J Pharm"},{"key":"BFnpp2011317_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","volume":"65","author":"MS Fanselow","year":"2010","unstructured":"Fanselow MS, Dong H-W (2010). Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65: 7\u201319.","journal-title":"Neuron"},{"key":"BFnpp2011317_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neulet.2010.03.028","volume":"474","author":"M Fendt","year":"2010","unstructured":"Fendt M, Imobersteg S, B\u00fcrki H, McAllister KH, Sailer AW (2010). Intra-amygdala injections of neuropeptide S block fear-potentiated startle. Neurosci Lett 474: 154\u2013157.","journal-title":"Neurosci Lett"},{"key":"BFnpp2011317_CR18","volume-title":"The Mouse Brain in Stereotaxic Coordinates with CDROM","author":"KBJ Franklin","year":"2007","unstructured":"Franklin KBJ, Paxinos G (2007). The Mouse Brain in Stereotaxic Coordinates with CDROM, 3rd edn. Academic Press, New York, NY, USA."},{"key":"BFnpp2011317_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1192\/bjp.188.4.305","volume":"188","author":"TA Furukawa","year":"2006","unstructured":"Furukawa TA, Watanabe N, Churchill R (2006). Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 188: 305\u2013312.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2011317_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1091\/mbc.6.5.509","volume":"6","author":"E Grady","year":"1995","unstructured":"Grady E, Garland A, Gamp P, Lovett M, Payan D, Bunnett N (1995). Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol Biol Cell 6: 509\u2013524.","journal-title":"Mol Biol Cell"},{"key":"BFnpp2011317_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","volume":"67","author":"AJ Guastella","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ et al (2010). Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 67: 692\u2013694.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011317_CR22","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1073\/pnas.0308250100","volume":"101","author":"J Gupte","year":"2004","unstructured":"Gupte J, Cutler G, Chen J-L, Tian H (2004). Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proc Natl Acad Sci USA 101: 1508\u20131513.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011317_CR23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1471-4159.2010.06693.x","volume":"113","author":"B Hambsch","year":"2010","unstructured":"Hambsch B, Chen B-G, Brennd\u00f6rfer J, Meyer M, Avrabos C, Maccarrone G et al (2010). Methylglyoxal-mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain. J Neurochem 113: 1240\u20131251.","journal-title":"J Neurochem"},{"key":"BFnpp2011317_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2009.03.023","volume":"455","author":"R-W Han","year":"2009","unstructured":"Han R-W, Yin X-Q, Chang M, Peng Y-L, Li W, Wang R (2009). Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-D-aspartate receptor antagonist in mice. Neurosci Lett 455: 74\u201377.","journal-title":"Neurosci Lett"},{"key":"BFnpp2011317_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","volume":"2","author":"T H\u00f6kfelt","year":"2003","unstructured":"H\u00f6kfelt T, Bartfai T, Bloom F (2003). Neuropeptides: opportunities for drug discovery. Lancet Neurol 2: 463\u2013472.","journal-title":"Lancet Neurol"},{"key":"BFnpp2011317_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.conb.2004.05.007","volume":"14","author":"YH Huang","year":"2004","unstructured":"Huang YH, Bergles DE (2004). Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol 14: 346\u2013352.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp2011317_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jchemneu.2009.01.003","volume":"37","author":"CS Hubbard","year":"2009","unstructured":"Hubbard CS, Dolence EK, Shires JA, Rose JD (2009). Identification of brain target neurons using a fluorescent conjugate of corticotropin-releasing factor. J Chem Neuroanat 37: 245\u2013253.","journal-title":"J Chem Neuroanat"},{"key":"BFnpp2011317_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuron.2007.06.001","volume":"54","author":"JTR Isaac","year":"2007","unstructured":"Isaac JTR, Ashby M, McBain CJ (2007). The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 54: 859\u2013871.","journal-title":"Neuron"},{"key":"BFnpp2011317_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1061186021000001823","volume":"10","author":"B Jansson","year":"2002","unstructured":"Jansson B, Bj\u00f6rk E (2002). Visualization of in vivo olfactory uptake and transfer using fluorescein dextran. J Drug Target 10: 379\u2013386.","journal-title":"J Drug Target"},{"key":"BFnpp2011317_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuron.2008.07.002","volume":"59","author":"K J\u00fcngling","year":"2008","unstructured":"J\u00fcngling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD et al (2008). Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59: 298\u2013310.","journal-title":"Neuron"},{"key":"BFnpp2011317_CR31","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1523\/JNEUROSCI.0115-05.2005","volume":"25","author":"SA Kr\u00f6mer","year":"2005","unstructured":"Kr\u00f6mer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L et al (2005). Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25: 4375\u20134384.","journal-title":"J Neurosci"},{"key":"BFnpp2011317_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neubiorev.2006.07.003","volume":"31","author":"R Landgraf","year":"2007","unstructured":"Landgraf R, Kessler MS, Bunck M, Murgatroyd C, Spengler D, Zimbelmann M et al (2007). Candidate genes of anxiety-related behavior in HAB\/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev 31: 89\u2013102.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2011317_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00213-008-1080-4","volume":"197","author":"SK Leonard","year":"2008","unstructured":"Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ et al (2008). Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berl) 197: 601\u2013611.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2011317_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neuroscience.2010.10.020","volume":"172","author":"SK Leonard","year":"2011","unstructured":"Leonard SK, Ring RH (2011). Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system. Neuroscience 172: 153\u2013163.","journal-title":"Neuroscience"},{"key":"BFnpp2011317_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFnpp2011317_CR36","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1371\/journal.pone.0002695","volume":"3","author":"S Meis","year":"2008","unstructured":"Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, Munsch T (2008). Identification of a neuropeptide s responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS ONE 3: e2695.","journal-title":"PLoS ONE"},{"key":"BFnpp2011317_CR37","first-page":"130","volume":"32","author":"K Ohkubo","year":"1994","unstructured":"Ohkubo K, Okuda M, Kaliner MA (1994). Immunological localization of neuropeptide-degrading enzymes in the nasal mucosa. Rhinology 32: 130\u2013133.","journal-title":"Rhinology"},{"key":"BFnpp2011317_CR38","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/npp.2010.207","volume":"36","author":"N Okamura","year":"2010","unstructured":"Okamura N, Garau C, Duangdao DM, Clark SD, J\u00fcngling K, Pape H-C et al (2010). Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology 36: 744\u2013752.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011317_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1124\/jpet.107.135103","volume":"325","author":"N Okamura","year":"2008","unstructured":"Okamura N, Habay SA, Zeng J, Chamberlin AR, Reinscheid RK (2008). Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 325: 893\u2013901.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011317_CR40","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/molecules14093754","volume":"14","author":"Y Ozsoy","year":"2009","unstructured":"Ozsoy Y, Gungor S, Cevher E (2009). Nasal delivery of high molecular weight drugs. Molecules 14: 3754\u20133779.","journal-title":"Molecules"},{"key":"BFnpp2011317_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/npp.2009.188","volume":"35","author":"T Perisic","year":"2010","unstructured":"Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M et al (2010). Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 35: 792\u2013805.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011317_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1476-5381.2009.00163.x","volume":"157","author":"L Raiteri","year":"2009","unstructured":"Raiteri L, Luccini E, Romei C, Salvadori S, Cal\u00f2 G (2009). Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. Br J Pharmacol 157: 474\u2013481.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2011317_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.brainres.2009.03.037","volume":"1293","author":"LN Ravindran","year":"2009","unstructured":"Ravindran LN, Stein MB (2009). Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res 1293: 24\u201339.","journal-title":"Brain Res"},{"key":"BFnpp2011317_CR44","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1124\/jpet.105.093427","volume":"315","author":"RK Reinscheid","year":"2005","unstructured":"Reinscheid RK, Xu Y-L, Okamura N, Zeng J, Chung S, Pai R et al (2005). Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315: 1338\u20131345.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011317_CR45","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1111\/j.1460-9568.2006.04820.x","volume":"23","author":"BAS Reyes","year":"2006","unstructured":"Reyes BAS, Fox K, Valentino RJ, Van Bockstaele EJ (2006). Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci 23: 2991\u20132998.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2011317_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2010.08.025","volume":"129","author":"H Rodrigues","year":"2011","unstructured":"Rodrigues H, Figueira I, Gon\u00e7alves R, Mendlowicz M, Macedo T, Ventura P (2011). CBT for pharmacotherapy non-remitters\u2014a systematic review of a next-step strategy. J Affect Disord 129: 219\u2013228.","journal-title":"J Affect Disord"},{"key":"BFnpp2011317_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopsych.2009.03.008","volume":"66","author":"S Rossi","year":"2009","unstructured":"Rossi S, De Capua A, Tavanti M, Calossi S, Polizzotto NR, Mantovani A et al (2009). Dysfunctions of cortical excitability in drug-na\u00efve posttraumatic stress disorder patients. Biol Psychiatry 66: 54\u201361.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011317_CR48","doi-asserted-by":"publisher","first-page":"17213","DOI":"10.1073\/pnas.1103318108","volume":"108","author":"MV Schmidt","year":"2011","unstructured":"Schmidt MV, Sch\u00fclke J-P, Liebl C, Stiess M, Avrabos C, Bock J et al (2011). Tumor suppressor downregulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. Proc Natl Acad Sci USA 108: 17213\u201317218.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011317_CR49","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s11064-010-0183-6","volume":"35","author":"C-G Shi","year":"2010","unstructured":"Shi C-G, Wang L-M, Wu Y, Wang P, Gan Z-J, Lin K et al (2010). Intranasal administration of nerve growth factor produces antidepressant-like effects in animals. Neurochem Res 35: 1302\u20131314.","journal-title":"Neurochem Res"},{"key":"BFnpp2011317_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06947.x","volume":"115","author":"W Si","year":"2010","unstructured":"Si W, Aluisio L, Okamura N, Clark SD, Fraser I, Sutton SW et al (2010). Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. J Neurochem 115: 475\u2013482.","journal-title":"J Neurochem"},{"key":"BFnpp2011317_CR51","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1210\/en.2005-1280","volume":"147","author":"KL Smith","year":"2006","unstructured":"Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV et al (2006). Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 147: 3510\u20133518.","journal-title":"Endocrinology"},{"key":"BFnpp2011317_CR52","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan KR, Brown M, Labou\u00e8be G, Yvon C, Creton C, Fritschy J-M et al (2010). Neural bases for addictive properties of benzodiazepines. Nature 463: 769\u2013774.","journal-title":"Nature"},{"key":"BFnpp2011317_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","volume":"692","author":"RG Thorne","year":"1995","unstructured":"Thorne RG, Emory CR, Ala TA, Frey WH (1995). Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 692: 278\u2013282.","journal-title":"Brain Res"},{"key":"BFnpp2011317_CR54","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","volume":"40","author":"RG Thorne","year":"2001","unstructured":"Thorne RG, Frey WH (2001). Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 40: 907\u2013946.","journal-title":"Clin Pharmacokinet"},{"key":"BFnpp2011317_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","volume":"152","author":"RG Thorne","year":"2008","unstructured":"Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH (2008). Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience 152: 785\u2013797.","journal-title":"Neuroscience"},{"key":"BFnpp2011317_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey WH (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127: 481\u2013496.","journal-title":"Neuroscience"},{"key":"BFnpp2011317_CR57","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1021\/jm200138r","volume":"54","author":"C Trapella","year":"2011","unstructured":"Trapella C, Pela M, Del Zoppo L, Calo G, Camarda V, Ruzza C et al (2011). Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R\/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). J Med Chem 54: 2738\u20132744.","journal-title":"J Med Chem"},{"key":"BFnpp2011317_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0165-0270(02)00033-X","volume":"116","author":"MP van den Berg","year":"2002","unstructured":"van den Berg MP, Romeijn SG, Verhoef JC, Merkus FWHM (2002). Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. J Neurosci Methods 116: 99\u2013107.","journal-title":"J Neurosci Methods"},{"key":"BFnpp2011317_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0166-4328(00)00240-0","volume":"115","author":"MM van Gaalen","year":"2000","unstructured":"van Gaalen MM, Steckler T (2000). Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 115: 95\u2013106.","journal-title":"Behav Brain Res"},{"key":"BFnpp2011317_CR60","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddl234","volume":"15","author":"J Vendelin","year":"2006","unstructured":"Vendelin J, Bruce S, Holopainen P, Pulkkinen V, Rytil\u00e4 P, Pirskanen A et al (2006). Downstream target genes of the neuropeptide S\u2013NPSR1 pathway. Hum Mol Genet 15: 2923\u20132935.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2011317_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cne.21159","volume":"500","author":"Y-L Xu","year":"2007","unstructured":"Xu Y-L, Gall CM, Jackson VR, Civelli O, Reinscheid RK (2007). Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500: 84\u2013102.","journal-title":"J Comp Neurol"},{"key":"BFnpp2011317_CR62","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","volume":"43","author":"Y-L Xu","year":"2004","unstructured":"Xu Y-L, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH et al (2004). Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487\u2013497.","journal-title":"Neuron"},{"key":"BFnpp2011317_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.psyneuen.2010.01.012","volume":"35","author":"H Zhu","year":"2010","unstructured":"Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, Yancopoulos GD et al (2010). Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 35: 1119\u20131132.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2011317_CR64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1523\/JNEUROSCI.3842-06.2007","volume":"27","author":"K Zushida","year":"2007","unstructured":"Zushida K, Sakurai M, Wada K, Sekiguchi M (2007). Facilitation of extinction learning for contextual fear memory by PEPA: a potentiator of AMPA receptors. J Neurosci 27: 158\u2013166.","journal-title":"J Neurosci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2011317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011317","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:51:48Z","timestamp":1713448308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2011317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,25]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFnpp2011317"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.317","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,25]]}}}